The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for ...

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its ...

(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of ...

Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...

Trials of Mana is a delightfully whimsical game that provides a charming world and cast of characters. It's one no RPG fan on ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

Boy Kills World’ on Hulu, a Hyperviolent Comix-Meets-Video Games Revenge Flick Starring Bill Sarsgard 'The Penguin' Series ...

Anant Madabhushi, PhD, of Emory University, told attendees at the International Myeloma Society 21st Annual Meeting & ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

The findings highlight the potential harms associated with receiving placebo in placebo-controlled IBD trials, "which might ...

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...